SCHEMBL4084296

SCHEMBL4084296

CCCCc1ccc(NC(=O)CCCC(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.66
GAA P10253 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
HPGD P15428 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
ALDH1A1 P00352 3/20 0.61
S1PR1 P21453 1/20 0.59
HDAC3 O15379 2/20 0.56
HDAC4 P56524 2/20 0.56
HDAC1 Q13547 2/20 0.56
HDAC7 Q8WUI4 2/20 0.56
HDAC2 Q92769 2/20 0.56
HDAC10 Q969S8 2/20 0.56
HDAC11 Q96DB2 2/20 0.56
HDAC8 Q9BY41 2/20 0.56
HDAC6 Q9UBN7 2/20 0.56
HDAC9 Q9UKV0 2/20 0.56
HDAC5 Q9UQL6 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081226 0.94 POLB (0.73) POLBNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL21998913 0.91 S1PR1 (0.64) POLBGAAL3MBTL1NPC1RAB9A
SCHEMBL21998911 0.91 S1PR1 (0.64) POLBGAAL3MBTL1NPC1RAB9A
SCHEMBL21998748 0.91 S1PR1 (0.64) POLBGAAL3MBTL1NPC1RAB9A
SCHEMBL13716202 0.91 POLB (0.73) POLBNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL9842929 0.87 POLB (0.73) POLBNPC1RAB9AHPGDSMN1; SMN2
SCHEMBL21998660 0.87 ENPP2 (0.64) POLBGAAL3MBTL1HPGDALDH1A1
SCHEMBL21998677 0.87 ENPP2 (0.64) POLBGAAL3MBTL1HPGDALDH1A1
SCHEMBL21998692 0.87 ENPP2 (0.64) POLBGAAL3MBTL1HPGDALDH1A1
SCHEMBL7824236 0.86 HDAC3 (0.71) POLBGAAL3MBTL1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD POLB 1568/4885GAA 20/4885L3MBTL1 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.